← Leaderboards
Rajan P. Kulkarni
Oregon Health & Science University
$1,394,503
Attributed
$1,394,503
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $705.4K · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
NIH$1,394,503 · 1
VA$0 · 1
By mechanism
R01$1,394,503 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Jonah B. Sacha$34,199,132
- David B Jacoby$23,001,349
Others in their field
Other Rising Stars on “Immune Modulating Agents”
- Moustafa Gabr · Weill Medical Coll Of Cornell Univ$4,950,845
- Amar Nijagal · University Of California, San Francisco$3,176,680
- Kathryn Marie Jones · Baylor College Of Medicine$3,103,804
- Alireza Hassani Najafabadi · Terasaki Institute For Biomedical Innovation$3,065,252
- Justin Blaine Schaal · University Of Southern California$3,025,760
- Hua Wang · University Of Illinois At Urbana-Champaign$2,593,656
Research focus
Immune Modulating AgentsImmunologyGene Expression ProfileImmune Checkpoint BlockadeAdverse EventImmune-Related Adverse EventsData SetFutureIl17 GeneImmuneBioinformaticsBiological ModelsCutaneousBiopsyAdrenal Cortex HormonesClinical TrialsCancer TherapyEvidence Based TreatmentColitisCellsCell TypeAutoimmuneClinical ManagementImmunomodulatory Therapies
Grant awards (3)
Identifying and modulating pathologic T cells that govern oral mucosal immune related adverse events from immune checkpoint blockade$689,062
R01 · FY2025 · DE · contact PI
Mechanistic Assessment and Treatment of Immune Related Adverse Events$0
I01 · FY2025 · VA · contact PI
Identifying and modulating pathologic T cells that govern oral mucosal immune related adverse events from immune checkpoint blockade$705,441
R01 · FY2024 · DE · contact PI